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AbsTrACT
background/aims Meibomian gland dysfunction 
(MGD) is the most common form of evaporative dry 
eye disease, but its pathogenesis is poorly understood. 
This study examined the histopathological features of 
meibomian gland (MG) tissue from cadaver donors to 
identify potential pathogenic processes that underlie 
MGD in humans.
Methods Histological analyses was performed on the 
MGs in the tarsal plates dissected from four cadaver 
donors, two young and two old adults, including a 
36- year- old female (36F) and three males aged 30, 63 
and 64 years (30M, 63M and 64M).
results The MGs of 36F displayed normal anatomy 
and structure, whereas the MGs of 30M showed severe 
ductal obstruction with mild distortion. The obstruction 
was caused by increased cytokeratin levels in association 
with hyperproliferation, but not hyperkeratinisation. In 
two older males, moderate to severe MG atrophy was 
noted. Cell proliferation was significantly reduced in the 
MG acini of the two older donors as measured by Ki67 
labelling index (6.0%±3.4% and 7.9%±2.8% in 63M 
and 64M, respectively) when compared with that of the 
two younger donors (23.2%±5.5% and 16.9%±4.8% 
in 30M and 36F, respectively) (p<0.001). The expression 
patterns of meibocyte differentiation biomarkers were 
similar in the older and younger donors.
Conclusion Our histopathological study, based 
on a small sample size, suggests potentially distinct 
pathogenic mechanisms in MGD. In the young male 
adult, hyperproliferation and aberrant differentiation of 
the central ductal epithelia may lead to the obstruction 
by overproduced cytokeratins. In contrast, in older adults, 
decreased cell proliferation in acinar basal epithelia 
could be a contributing factor leading to MG glandular 
atrophy.
InTroduCTIon
Meibomian glands (MGs), located in the upper 
and lower tarsal plates of the eyelids, are holocrine 
glands composed of secretory acini surrounding a 
central duct.1 Based on their anatomical locations, 
acinar epithelia cells are classified as basal (germi-
native or proliferative), differentiating, mature 
and superficial degenerated cells. Each acinus at 
its basal circumference comprises a single layer of 
proliferative epithelial cells, which are essential for 
acinar regeneration. When the basal cells start to 
differentiate, they move inward and mature into 
lipid- producing meibocytes. After reaching matu-
rity, the meibocytes disintegrate as holocrine cells 
and release lipids (meibum) into the short collecting 
ductules that connect with the central secretory 
duct lined by the squamous epithelial cells. Meibum 
produced from the mature and decomposed meibo-
cytes travels through the ductule to the central duct 
and is discharged through the central duct and onto 
the ocular surface via the MG orifice. The secreted 
meibum constitutes the outermost layer of the 
tear film, overlying the inner mucoaqueous layer 
and providing tear film stability.2 Normal meibum 
from healthy MGs forms a barrier against tear film 
evaporation and protects the ocular surface from 
microbial and environmental insults such as dust 
and pollen.
Meibomian gland dysfunction (or disease; MGD) 
is a term broadly used to encompass various func-
tional abnormalities of MGs.3–5 Conventionally, 
MGD can be classified as MG ductal obstruc-
tion, MG hyposecretion and MG hypersecretion. 
MG ductal obstruction and hyposecretion are 
more common than MG hypersecretion, which 
is frequently associated with eyelid inflammation 
and occurs in rosacea, chalazion and allergy.6–8 
Animal models of MGD have shown that ductal 
hyperkeratinisation can result in ductal obstruction, 
meibum stasis, cystic dilation and, eventually, acinar 
atrophy and MG dropouts.9 Keratinised materials, 
however, are not normally present in the ducts of 
human MGs.10 Compromised meibum quality is 
another contributing factor to ductal obstruction.11 
Studies in both animals and humans suggest that 
acinar epithelial abnormalities, such as diminished 
renewal of acinar basal cells and/or impaired meibo-
cyte differentiation, contribute to the pathogenesis 
of age- related MGD.12–14 Androgen deficiency and 
medications, such as isotretinoin, are also thought 
to play a role in MGD.15–17
The high prevalence of MGD and its diverse 
pathology implicate that it is a multifactorial 
disease,18 19 but the histopathological changes and 
underlying molecular mechanisms of MGD have 
not been extensively elucidated, which makes it 
clinically challenging to diagnose and manage 
MGD effectively. To gain a better understanding 
of the pathogenesis of MGD, we performed 
histopathological examinations and biomarker 
expression analyses on MG tissues of four cadaver 
donors, including two young adults and two older 
adults. Our current study implies that fundamen-
tally different pathogenic mechanisms underlie 
MGD. Despite the limited sample size in this study, 
our findings unveiled previously poorly described 
pathogenic mechanisms of MGD and shed light 
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FASN, fatty acid synthase; PCNA, proliferating cell nuclear antigen; PPARγ, 
peroxisome proliferator activated receptor gamma.
Figure 1 Human MG in tarsal plate and histology in MG tissue from 
four cadaver donors. (A–D) Tarsal plates dissected from cadavers’ 
eyelids, designated as 36F (A), 30M (B), 64M (C) and 63M (D), were 
photographed directly before trimming off some of the orbicularis oculi 
muscle. Note: The thickness of the dissected tissue and setting of the 
photographic illumination gave rise to different appearance in tissue 
transparency. The two older donors (C, D) showed moderate to severe 
MG atrophy with glandular shortening (arrow in C) or dropout (arrow in 
D). (E–H) Histology (H&E staining). The circumference of MG acinus (a) 
in the 36F is made of a layer of basal epithelium that surrounds a cluster 
of lipid (meibum)- producing meibocytes (E). In 30M (F), thickened ductal 
epithelia (arrows in F) and hypercellularity were noted in the Cd. MGs 
of the two older donors (G and H) exhibited fibrotic areas with MG 
remnants (G’, arrowheads) and acinar atrophy (H, arrows). Scale bar 
denotes 100 µm. 36F, 36- year- old female; 30M, 30- year- old male; 63M, 
64- year old male; 64M, 64- year old male; a, acinus; Cd, central duct; d, 
ductule; MG, meibomian gland.
mechanism- targeted diagnostic and therapeutic strategies for 
MGD.
MATerIAls And MeThods
Acquisition of donor tarsal tissues
Fresh tarsal tissues from four cadaver donors were obtained 
from Mid- America Transplant (St. Louis, Missouri, USA). The 
donors were free of known systemic illness and included two 
young adults and two older adults: a 30- year- old male (30M), 
a 36- year- old female (36F), a 63- year- old male (63M) and a 
64- year- old male (64M). The medical and ocular histories of the 
donors were deidentified prior to removal of the tarsal plates 
from the inner upper eyelids of the fresh cadavers. The removal 
of donor corneas and tarsal plates was performed by eye bank 
staff under the standard protocol for procurement of ocular 
tissues. The use of human tissues in research conformed to the 
provisions of the Declaration of Helsinki and was exempted by 
the Washington University Human Research Protection Office, 
St. Louis, Missouri, USA.
histology, immunofluorescence, immunohistochemistry and 
quantification of cell proliferation
Human tarsal tissues were fixed overnight in 4% paraformalde-
hyde in phosphate- buffered saline (PBS) and then processed for 
embedding in paraffin. Tissue sections (5 µm) were treated with 
xylene; rehydrated in a decreased ethanol series; and subjected 
to H&E staining, immunofluorescence or immunohistochem-
istry.20 For antigen retrieval of immunostaining, tissue sections 
were boiled in 10 mM sodium citrate buffer for 10 min and then 
cooled to room temperature. To block endogenous peroxidase 
activity, sections were treated with 3% hydrogen peroxide in 
PBS for 20 min. Tissue sections were blocked with 3% horse 
serum in PBST (PBS plus 0.1% Tween-20) for 1 hour at room 
temperature and then incubated overnight at 4°C with primary 
antibodies diluted in the same buffer (table 1). Slides were 
washed with PBS, incubated at room temperature for 1 hour 
with either fluorophore- conjugated or biotinylated secondary 
antibodies and then washed with PBS. For immunofluorescence, 
cell nuclei were stained with 4′,6- diamidino-2- phenylindole 
and slides were mounted with Mowiol (Sanofi- Aventis, Bridge-
water, New Jersey, USA). For immunohistochemistry, sections 
were incubated with Vectastain Elite ABC Reagent (PK-6100; 
Vector Laboratories, Burlingame, California, USA) and colour 
was developed by using 3,3′-diaminobenzidine as a substrate 
(D4293; Sigma- Aldrich, St. Louis, Missouri, USA). Sections were 
counterstained with haematoxylin for visualisation of cell nuclei.
Quantification of the cell proliferation was determined by Ki67 
labelling index which is the ratio of Ki67- positive cells to the 
total basal epithelial cells counted, and the data were presented 
as means±SD. Unpaired t- tests were used to compare the Ki67 
index among individual donors or between the younger age group 
(30M and 36F) and the older age group (63M and 64M). A p 
value of less than 0.001 was considered statistically significant.
resulTs
histology of MGs in human cadaver donors
The MGs in the tarsal plates dissected from cadaver eyelids 
were first examined for gross morphology (figure 1A–D). The 
MGs of 36F were uniformly distributed in the tarsal plate and 
acini were evenly sized and appeared normal (figure 1A). Mild 
ductal distortion was observed in the MGs of 30M (figure 1B). 
In the two older donors (63M and 64M), MG atrophy, including 
glandular shortening and dropouts (arrows in figure 1C,D), was 
readily visualised in tarsal tissues.
Histology revealed notable variations in the acinar and ductal 
structure of MGs among the donors (figure 1E–H). In 36F, the 
lipid- producing acini were connected to the central duct by short 
branching ductules (figure 1E). By comparison, in 30M the MG 
central ducts were thickened from epithelial hypercellularity 
and filled with cellular debris and nuclear fragments (figure 1F, 
arrows). Compared with the two younger donors (30M and 
36F), the MG tissues of the two older donors (64M and 63M) 
displayed altered features, with obliterated (figure 1G’) and 
shrunken acini (figure 1H) scattered among areas containing 
normal- appearing acini (figure 1G).
ductal obstruction without increased keratinisation 
biomarkers
Krt10 and its type II pair Krt1 are considered to be keratinisation 
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Figure 2 Expression of Krt10, Krt1 and Krt14 in MGs of the two 
young donors, one with normal- appearing MGs (36F) and the other with 
evidence of ductal obstruction (30M). (A,B) Krt10 was expressed in the 
suprabasal layers of ductules and central duct in 36F (A, red arrows). 
In the central duct of 30M, the Krt10- positive suprabasal layers (inset 
in B, red arrow) was ‘sandwiched’ between two Krt10- negative layers, 
presumably the basal layer (black arrow) and the superficial layer (open 
arrow). Ductal blockage (arrowhead in B) was caused by Krt10- negative 
proteins mixed with cell nuclear fragments. (C, D) Krt1 expression level 
in the MGs of 36F and 30M was high in the ductules and reduced in the 
suprabasal layer of the central duct (as indicated by arrows in C). Similar 
to the Krt10 pattern seen in MGs of 30M (B), the superficial layer of the 
central duct in this donor was negative for Krt1 (open arrows in D). (E, 
F) Krt14 was highly expressed in the MG acinar and ductule epithelia 
in both 36F (E) and 30M (F). Krt14 expression was limited to the basal 
epithelium in the central duct in 36F (arrows in E). The thickness of the 
Krt14- positive layer was notably increased in the central duct of 30M 
(F, black arrow in the inset). Scale bar denotes 100 µm. 36F, 36- year- old 
female; 30M, 30- year- old male; a, acinus; Cd, central duct; d, ductule; 
MG, meibomian gland.
keratinocytes.21 To investigate whether hyperkeratinisation of 
the ductal epithelia may account for the ductal obstruction in 
30M, the expression patterns of Krt10 and Krt1 in MGs of the 
four donors were examined. We first verified the respective spec-
ificity of anti- Krt10 and anti- Krt1 antibodies by confirming their 
positive staining patterns at the mucocutaneous junction (MCJ) 
of cadaver eyelids (online supplementary figure S1). Expression 
of both Krt10 and Krt1 was interrupted at the MCJ where the 
epidermal epithelium transitions into the conjunctival epithelium 
(indicated by open arrows in online supplementary figure S1). 
Krt10 and Krt1 expression patterns in MGs of 36F, 63M and 
64M differed from those of 30M. In 36F, both Krt10 and Krt1 
were present in the suprabasal layer of the collecting ductules 
and the central duct (arrows in figure 2A,C). Similar patterns 
were seen in the MGs of 64M and 63M (data not shown). 
Interestingly, in the central duct of 30M, a Krt10/Krt1- positive 
suprabasal layer (red arrow in figure 2B inset) was sandwiched 
between the basal layer (black arrow) and a yet uncharacterised 
Krt10/Krt1- negative superficial layer (figure 2D, open arrows). 
The Krt10/Krt1- positive middle layer in the central duct of 30M 
was not thicker than the corresponding layer in the central duct 
of the 36F. Furthermore, the debris blocking the central duct of 
30M did not stain positive for Krt10 (figure 2B, arrowhead). 
Therefore, the Krt10/Krt1 expression pattern in 30M suggests 
that hyperkeratinisation is unlikely to be the direct cause of 
ductal obstructive MGD in this case.
The abnormal Krt10/Krt1 expression pattern in the central 
duct of 30M prompted us to investigate the expression of Krt14, 
a marker for basal cells in most epithelial tissues, including 
the skin.21 In MGs of both 30M and 36F, Krt14 was highly 
expressed in the acini and in the basal epithelium of the central 
duct (figure 2E,F). However, in 30M, Krt14 expression was 
found not only in the basal layer of the central duct but also in 
multiple suprabasal layers (figure 2F inset). The abnormal and 
expanded expression of Krt14 in the central ductal epithelia was 
confirmed on multiple MGs from 30M and also by using cross 
sections of MGs from this donor (data not shown). These results 
suggest abnormal proliferation and differentiation of the central 
ductal epithelia may cause ductal obstruction in this donor.
ductal obstruction from overproduction of cytokeratins 
linked to hyperproliferation
Keratin 16 (Krt16) is typically expressed in stratified squamous 
epithelia and certain glandular tissues.20–22 Overexpression of 
Krt16 and its type II pair Krt6, along with Krt17 overexpression, 
is associated with keratinocyte hyperproliferation and consid-
ered to be hallmarks for psoriasis, a chronic inflammatory skin 
disease.23 24 To explore the role of these cytokeratins in MGD, 
we examined the expression of keratins 16, 6a and 17 in the 
MGs of 30M, 36F and 64M (figure 3).
In MGs of 36F and 64M, Krt16 was mostly expressed in the 
ductules adjacent to the central duct, moderately expressed in 
the acinar periphery and minimally expressed in the MG central 
duct (figure 3A,C). In contrast, in the MG of 30M, Krt16 was 
overexpressed in the central duct (figure 3B, top right inset) and 
a ‘plug’, which was not stained by Krt16, was present in the 
orifice (figure 3B, red arrow in bottom left inset). Similar to the 
expression of Krt16, Krt6a expression in the MGs of 36F and 
64M was greatest in the ductules adjacent to the central duct 
but attenuated in the central duct (figure 3D,F). In contrast, 
Krt6a was overexpressed in the central ducts of 30M (figure 3E), 
consistent with the aforementioned Krt16 overexpression in this 
young male donor.
Like Krt16 in psoriatic dermatitis, overexpression of Krt17 
has been found in this disease.25 In our study of MGs, Krt17 
was distributed in acinar and ductal epithelia more ubiquitously 
than Krt16/Krt6a (figure 3G–I). The Krt17 level appeared to be 
increased in the thickened central ducts of 30M, as compared with 
Krt17 expression in the central ducts of 36F and 63M (compare 
figure 3H with figure 3G,I). Taken together, the findings suggest 
that overproduction of Krt16/Krt6a and Krt17 in the central ductal 
epithelia of the 30M is likely the underlying or a contributing cause 
of ductal obstruction in this younger male donor, who probably 
had clinically undetected obstructive MGD.
hyperproliferation and aberrant differentiation of central 
ductal epithelia
Because overexpression of Krt16 and Krt17 is associated with 
keratinocyte hyperproliferation, we examined the cell prolifera-
tion markers Ki67 and proliferating cell nuclear antigen (PCNA) in 
central ductal epithelia and compared the levels in 30M and 36F 
(figure 4A–D). Both Ki67- and PCNA- positive cells were markedly 
increased in the basal epithelia of the central duct of 30M when 
compared with the levels in the central duct of 36F. Furthermore, 
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Figure 3 Expression of Krt16, Krt6a and Krt17 in MGs of an older 
donor (64M) and of the two young donors, one with normal- appearing 
MGs (36F) and the other with evidence of ductal obstruction (30M). 
(A–C) Krt16 protein was mostly distributed in MG ductules and 
decreased in the MG central duct of 36F (A) and 64M (C) as compared 
with Krt16 expression in 30M (B). The central ductal cells in 30M 
showed Krt16 overexpression (B, montage and inset on the top right) 
and an orifice ‘plug’ (B, red arrow in bottom left inset). (D–F) Krt6a 
expression was similar to Krt16 expression in the MG ductules of 36F 
(D) and 64M (F). Krt6a overproduction was seen in the central duct of 
30M (E). (G–I) Krt17 was ubiquitously expressed in the MGs of 30M, 
36F and 64M, with a higher level in the epithelial cells of ductules. 
Krt17 overexpression was noted in the central duct of 30M, but not in 
the central duct of 36F and 64M (H). Scale bar denotes 100 µm. 36F, 
36- year- old female; 30M, 30- year- old male; 64M, 64- year old male; a, 
acinus; Cd, central duct; d, ductule; MG, meibomian gland.
Figure 4 Expression of cell proliferation markers in MGs of the donor 
with ductal obstruction (30M), the donor with normal- appearing MGs 
(36F) and one of the older donors (63M). (A, B) Ki67 expression. Ki67- 
positive cells were rarely identified in the basal epithelia of the central 
ducts in 36F (A). In contrast, many Ki67- positive cells were noted in the 
basal epithelia of 30M (B, black arrows). (C, D) PCNA expression was 
found in the nuclei of the acinar basal epithelium of 36F (C, arrow), 
and expression was diminished in cells differentiating into meibocytes. 
PCNA- expressing cells were rarely detected in the MG central duct 
in 36F (C), whereas in 30M PCNA- positive cells were abundant in 
the epithelia of the central duct (D, black arrow). In 30M, cell nuclear 
fragments were retained in the superficial layer of the MG central 
duct (B and D, red arrows). (E) Ki67 labelling index in MG ductal basal 
epithelia. Cell proliferation rate in ductal basal epithelia was higher in 
30M than in 36F and 63M (p<0.001). Scale bar denotes 100 µm. 36F, 
36- year- old female; 30M, 30- year- old male; 63M, 63- year old male; 
a, acinus; CD, central duct; D, ductile; MG, meibomian gland; PCNA, 
proliferating cell nuclear antigen.
was higher than that of 36F and 64M (p<0.001) (figure 4E). The 
histopathology also showed that nuclear fragments were retained 
in the thickened suprabasal layer of the central duct of 30M (red 
arrows in figure 4B,D), suggesting the abnormal differentiation of 
the ductal epithelia. These results together suggest that the poten-
tial cause of obstructive MGD in 30M is epithelial hyperprolifera-
tion with aberrant differentiation, associated with overproduction 
of cytokeratins, leading to the accumulation of proteins and 
nuclear debris in the central duct.
Age-related decline of acinar cell renewal and gland atrophy
Transcription factor p63 (TP63), a member of p53 family, is 
expressed by proliferative stem cells or progenitor cells in several 
stratified epithelia.26 27 We found p63 expression in the basal 
epithelia of MG acini, the ductule and the central duct in MG 
tissue of each donor (figure 5A,B and data not shown for 30M 
and 64M), but p63 expression was reduced in some of the MG 
basal acini of 63M (figure 5B, red ‘a’). When cell proliferation 
marker Ki67 was colocalised with p63, Ki67- positive cells were 
also notably decreased in the acini of 63M, as compared with 
the number of Ki67- positive cells in the acini of 36F (compare 
figure 5B with figure 5A). The Ki67 labelling index was signifi-
cantly lower in the older group (6.0%±3.4% and 7.9%±2.8% 
for 63M and 64M, respectively) than that in the younger group 
(23.2%±5.5% and 16.9%±4.8% for 30M and 36F, respec-
tively) (p<0.001) (figure 5C), suggesting that this decrease 
of cell proliferation may compromise acinar cell renewal and 
haemostasis in older individuals, leading to age- related MG 
atrophy (figure 1D).
The main function of MGs is to produce and secrete lipids 
(meibum) that coat the outer tear film and prevent its evapo-
ration.28 The expression patterns of the meibocyte differentia-
tion markers, peroxisome proliferator activated receptor gamma 
and fatty acid synthase, were compared between the 36F and 
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Figure 5 Expression of cell proliferation and differentiation 
biomarkers in MG acini of the 30- year- old, 36- year- old, 63- year- old and 
64- year- old donors. (A, B) p63 (green nuclear staining) was expressed 
in acinar (a) and ductal basal epithelia in the MGs of 36F (A) and 63M 
(B). Notably fewer Ki67- positive cells (red nuclear staining pointed 
by white arrows) were present in Mg acini of 63M acini (B), when 
compared with those in 36F’s acini (A). Reduction of p63 expression 
was noted in 63M (marked with red ‘a’ in B). (C) Bar graph depicting 
the Ki67 labelling index in MG acinar basal epithelia. The proliferation 
rate in basal acini was significantly higher in two younger donors (36F 
and 30M) than in the two older donors (64M and 63M) (p<0.001). 
(D–G) PPARγ expression (D and E, red arrows) and FASN expression 
(F and G, black arrows) were relatively intense in newly differentiated 
meibocytes and attenuated to background level in mature meibocytes 
(D and E, open arrows) in both 36F and 64M. Scale bar denotes 100 µm. 
36F, 36- year- old female; 30M, 30- year- old male; 63M, 63- year old male; 
64M, 64- year old male; a, acinus; Cd, central duct; d, ductile; FASN, fatty 
acid synthase; MG, meibomian gland; PPARγ, peroxisome proliferator 
activated receptor gamma.
MGs and an older donor with age- related atrophy. The staining 
patterns for these differentiation biomarkers were similar in 
the MGs of 36F and 64M (figure 5D–G), suggesting that, in 
this older donor’s acini where cell proliferation was reduced 
(figure 5C), the expression of meibocyte differentiation markers 
appeared to be normal.
dIsCussIon
MGD is the major cause of evaporative dry eye disease and has 
diverse aetiologies.3 18 29 Ductal obstruction and acinar or glan-
dular atrophy are common features of MGD. To understand the 
pathogenesis of MGD, it is of paramount importance to inves-
tigate the histopathological changes in human MGs. This study 
describes the histological findings and the results of immunos-
taining for selective biomarkers in the MGs of cadaver tarsal 
plate tissues from two donors in the fourth decade of life (young 
age group) and two donors in the seventh decade of life (older 
age group). Despite of limited sample size, the data shed light on 
the notion that multiple pathogenic factors can contribute to the 
development of MGD.
Hyperkeratinisation of ductal epithelia has been shown in 
animal models of MGD to alter the structure and function of 
MGs by plugging the MG central ducts, causing ductal dilation 
and disruption of meibum excretion.9 10 Ductal plugs comprising 
non- keratinised epithelial cells have also been observed in animal 
models of MGD.12 30 In this current study of human MGs, the 
tissue debris blocking the central ducts of 30M did not display 
the typical characteristics of hyperkeratinisation (figures 2 and 
3). In the MGs of this donor, the keratinisation biomarkers 
Krt10 and Krt1 were present in the middle layer, above the 
Krt14- expressing basal layer, but underneath the superficial 
layer of the central ductal epithelia. Based on this abnormal 
expression pattern of the keratinisation biomarkers (Krt10 and 
Krt1), an alternative mechanism other than hyperkeratinisation 
seems likely to be the cause of ductal obstruction in this young 
male adult.
We propose that hyperproliferation and aberrant differentia-
tion of the central ductal epithelial cells led to MG ductal obstruc-
tion and plugging in 30M. This conclusion is supported by the 
presence of overproduction of Krt6a/Krt16/Krt17 (figure 3) and 
increased cell proliferation markers (figure 4). Besides ductal 
obstruction, excessive cytokeratins are also disruptive to the 
quality of meibum as well as the stability of the lipid layer in 
the tear film. Meibum undergoes a maturation process as it is 
secreted into the ductules, with protein removal and/or lipid 
accumulation prior to excretion onto the ocular surface and 
incorporation into the tear film.31 It has been shown that the 
addition of purified cytokeratins to meibum lipid can affect the 
fluidity of the meibum.32 Such an increase in the protein–lipid 
ratio correlates with increased meibum viscosity.33 Thus, it is 
conceivable that overproduction and retention of Krt6a/Krt16/
Krt17 in the central duct, as found in the MGs of 30M, could 
have a profound effect on meibum quality and fluidity and lead 
to MG obstruction and the eventual development of MGD.
MGD is often associated with certain skin diseases, such as 
acne rosacea, atopic dermatitis, seborrhoeic dermatitis and 
psoriasis.6 It was reported that patients with psoriasis vulgaris 
have a high prevalence of obstructive MGD, characterised by 
ductal plugging and impaired meibum secretion.34 In psoriatic 
skin, the Krt6/Krt16 pair and Krt17, along with cell prolifera-
tion maker Ki67, are considered to be biomarkers for keratino-
cyte hyperproliferation.23 The pertinent medical record of the 
30M prior to corneal and tarsal plate removal did not reveal any 
indication of psoriatic skin lesions. Krt6 and Krt16 are known 
as stress- activated keratins.35 Our interesting findings in this 
donor’s MGs imply a potential utility of Krt6a/Krt16 staining of 
meibum excreta as diagnostic biomarkers to ascertain the diag-
nosis of obstructive MGD.
It is well documented that the process of ageing is associated 
with a decrease in the number of MGs along with an increase in 
MG dropouts.5 10 14 15 Postulated factors include age- mediated 
hormonal changes, stem cell attenuation and growth factor defi-
ciency. Other studies have demonstrated reduced Ki67 nuclear 
staining in old murine and human MGs,5 14 which is consistent 
with our current finding of a reduced number of Ki67- positive 
cells in the acinar basal epithelia in MGs of 64M and 63M 
(figure 5C). Furthermore, we found that p63, a transcription 
factor for epithelial morphogenesis and stemness, was also 
downregulated in some acini in the MGs of 63M (figure 5B). 
Taken together, these observations suggest that a deficiency in 
acinar basal cell proliferation and/or MG progenitor/stem cell 
renewal may be a major contributing factor for the development 
of age- related MGD. In searching for the endogenous regulators 
responsible for MG cell renewal and homeostasis, we recently 
found that fibroblast growth factor receptor 2 (FGFR2) is highly 
expressed in both murine and human MGs. Using an inducible 
conditional knockout mouse model, we have demonstrated 















ol: first published as 10.1136/bjophthalm





1004 Reneker LW, et al. Br J Ophthalmol 2020;104:999–1004. doi:10.1136/bjophthalmol-2019-314466
Clinical science
proliferation and renewal.20 Nevertheless, the significance of 
FGFR2 and its ligands in human MG homeostasis awaits further 
investigations.
In summary, while our study is limited by the small sample 
size due to the poor availability of donor eyelids, the histopatho-
logical and biomarker analyses of MG tissues from a young 
donor with normal- appearing MGs, a young donor with ductal 
obstruction and two donors in their early 60s shed insights into 
the diverse underlying pathogenic mechanisms of MGD. The 
findings of our study suggest that ductal epithelial hyperprolif-
eration and abnormal differentiation, without notable hyperke-
ratinisation, can lead to MG obstruction, as in the case of 30M, 
whereas a decline in acinar cell proliferation and renewal is more 
likely the underlying cause of age- related MG atrophy, as in the 
two older donors. The findings also suggest that overexpression 
of hyperproliferative keratins in meibum may serve as potential 
biomarkers to diagnose specific type of obstructive MGD.
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